Free Trial

Integer (ITGR) Competitors

Integer logo
$121.73 +1.26 (+1.05%)
Closing price 03:59 PM Eastern
Extended Trading
$121.80 +0.07 (+0.06%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ITGR vs. BDSX, ELV, BAX, HOLX, MASI, GMED, TFX, ATEC, ATRC, and IART

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Globus Medical (GMED), Teleflex (TFX), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "medical" sector.

Integer vs. Its Competitors

Integer (NYSE:ITGR) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

In the previous week, Integer had 2 more articles in the media than Biodesix. MarketBeat recorded 2 mentions for Integer and 0 mentions for Biodesix. Integer's average media sentiment score of 0.64 beat Biodesix's score of 0.00 indicating that Integer is being referred to more favorably in the media.

Company Overall Sentiment
Integer Positive
Biodesix Neutral

99.3% of Integer shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 2.2% of Integer shares are owned by company insiders. Comparatively, 30.1% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Integer presently has a consensus price target of $145.00, indicating a potential upside of 19.11%. Biodesix has a consensus price target of $1.75, indicating a potential upside of 468.18%. Given Biodesix's higher possible upside, analysts plainly believe Biodesix is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00
Biodesix
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Integer has a net margin of 4.38% compared to Biodesix's net margin of -54.28%. Integer's return on equity of 11.95% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer4.38% 11.95% 6.04%
Biodesix -54.28%-167.28%-39.96%

Integer has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Biodesix has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.72B2.47$119.90M$2.1157.69
Biodesix$74.46M0.61-$42.93M-$0.29-1.06

Summary

Integer beats Biodesix on 15 of the 17 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$4.25B$6.82B$5.57B$20.55B
Dividend YieldN/A1.29%5.25%3.74%
P/E Ratio57.6925.5227.2128.04
Price / Sales2.4794.23416.2641.55
Price / Cash13.2720.6637.0622.25
Price / Book2.524.778.084.61
Net Income$119.90M$174.76M$3.16B$982.91M
7 Day Performance0.61%1.48%3.74%3.25%
1 Month Performance-0.67%0.51%3.88%4.36%
1 Year Performance6.17%15.20%34.26%14.94%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
3.6804 of 5 stars
$121.73
+1.0%
$145.00
+19.1%
+4.7%$4.25B$1.72B57.6911,000
BDSX
Biodesix
3.4039 of 5 stars
$0.28
+12.7%
$1.75
+520.1%
-80.5%$36.69M$71.32M-0.97220
ELV
Elevance Health
4.9663 of 5 stars
$389.42
+2.1%
$498.87
+28.1%
-34.6%$86.19B$177.01B15.19104,200Trending News
Upcoming Earnings
Analyst Forecast
BAX
Baxter International
4.2607 of 5 stars
$30.33
-0.2%
$37.25
+22.8%
-12.2%$15.60B$10.64B-27.5738,000Analyst Forecast
HOLX
Hologic
4.7566 of 5 stars
$65.16
+0.2%
$77.42
+18.8%
-11.9%$14.49B$4.03B27.497,063News Coverage
Positive News
Analyst Forecast
MASI
Masimo
3.7236 of 5 stars
$168.22
+0.0%
$191.60
+13.9%
+54.7%$9.12B$2.09B-18.345,600News Coverage
GMED
Globus Medical
4.9496 of 5 stars
$58.98
+0.6%
$94.00
+59.4%
-16.2%$7.93B$2.52B44.015,300
TFX
Teleflex
4.7316 of 5 stars
$118.21
-1.1%
$164.63
+39.3%
-45.5%$5.28B$3.05B37.2914,100Positive News
ATEC
Alphatec
4.3947 of 5 stars
$11.10
+0.2%
$17.89
+61.2%
+6.0%$1.62B$611.56M-9.65700Positive News
ATRC
AtriCure
3.252 of 5 stars
$32.77
+1.5%
$50.67
+54.6%
+43.5%$1.60B$465.31M-40.461,300Positive News
IART
Integra LifeSciences
4.0846 of 5 stars
$12.27
-0.2%
$18.63
+51.8%
-55.0%$955.08M$1.61B-32.294,396

Related Companies and Tools


This page (NYSE:ITGR) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners